IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,067,609 | +429.5% | 59,510 | +183.9% | 0.01% | +800.0% |
| Q2 2022 | $201,626 | -73.5% | 20,959 | -53.6% | 0.00% | -75.0% |
| Q1 2022 | $760,228 | -29.2% | 45,171 | -31.7% | 0.00% | -50.0% |
| Q3 2021 | $1,073,708 | -31.9% | 66,115 | -73.6% | 0.01% | -20.0% |
| Q2 2021 | $1,577,500 | – | 250,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,729,041 | $10,685,000 | 4.26% |
| Soleus Capital Management, L.P. | 3,380,979 | $20,894,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 1,579,093 | $9,759,000 | 3.52% |
| Stonepine Capital Management, LLC | 875,180 | $5,409,000 | 2.92% |
| Samsara BioCapital, LLC | 2,372,476 | $14,664,000 | 2.70% |
| Ghost Tree Capital, LLC | 1,125,000 | $6,953,000 | 1.63% |
| Octagon Capital Advisors LP | 680,036 | $4,203,000 | 1.58% |
| Altium Capital Management LP | 902,633 | $5,578,000 | 1.55% |
| Vivo Capital, LLC | 5,966,527 | $36,873,000 | 1.30% |
| FRAZIER MANAGEMENT LLC | 2,544,500 | $15,725,000 | 1.26% |